Joint Ventures, Alliances & Partnerships

Joint Ventures, Alliances & Partnerships 

NPIL is well positioned as a partner of choice for any multinational company looking at the Indian market. It has an unmatched record of managing Joint Ventures/Alliances/Partnerships and a proven commitment to IPR. Capabilities include strong brand management, sales and marketing, a US FDA site-approved plant for on-and-off patent APIs and Intermediates, Basic Research, process innovation, Custom Chemical Synthesis, Formulations R&D, NDDS, and a world-class Clinical Research Organisation.

Few Indian Pharmaceutical have as strong and consistent record in successfully and ethically managing JVs/Alliances and Partnerships as NPIL has. 

Its policy of respecting IPR and managing partnerships, in keeping with both the letter and the spirit of written agreements, has been widely respected and commended by its partners.

Today, NPIL has JVs/Alliances with some of the finest global names in the Pharmaceutical and Healthcare industry. Its major current partnerships (including JVs/Alliances) are: 

In-licensing agreements:

Gilead Sciences, USA

Biogen Idec Inc.

Genzyme Corporation

Laboratories Pierre Fabre

Ethypharm

Biosyntech Inc.

Cheisi, Italy

JVs for Indian Market

Allergan Inc., USA

Boots Plc., UK